West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

Interest Coverage Ratio: 1737.00x

Is the interest coverage ratio high or low?

The interest coverage ratio of 1737.00x is 555% above its 5-year average of 265.31x, near the high end of its 5-year range (45.30x–1737.00x).

As of Saturday, June 27, 2026. 79.09% above its 12-month average of 969.93x.

Interest Coverage

WST Interest Coverage Ratio

1737.00x

Reported quarterly interest coverage; no daily interpolation.

+3155.86% 5Y
WST Interest Coverage Ratio

WST Average Interest Coverage Ratio Chart

WST Interest Coverage Ratio

WST Current vs Average Interest Coverage Ratio Chart

WST Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

1737.00x

INTEREST COVERAGE RATIO AVG TTM

969.93x

INTEREST COVERAGE RATIO AVG 3Y

129.22x

INTEREST COVERAGE RATIO AVG 5Y

89.16x

INTEREST COVERAGE RATIO AVG 10Y

57.59x

INTEREST COVERAGE RATIO AVG 15Y

40.05x

INTEREST COVERAGE RATIO AVG 20Y

33.25x

CURRENT VS TTM AVG

+79.09%

CURRENT VS 3Y AVG

+1244.22%

CURRENT VS 5Y AVG

+1848.20%

CURRENT VS 10Y AVG

+2916.14%

CURRENT VS 15Y AVG

+4237.29%

CURRENT VS 20Y AVG

+5123.79%

WST Competitors' Interest Coverage Ratio

NAMEMARKET CAPINTEREST COVERAGE RATIOTTM3Y5Y
West Pharmaceutical Services, Inc. (WST)$24.79B1737.00x969.93x129.22x89.16x
Waters Corporation (WAT)vs ›$24.41B12.84x11.03x12.05x13.28x
Mettler-Toledo International Inc. (MTD)vs ›$25.54B16.32x15.71x16.43x18.17x
Quest Diagnostics Incorporated (DGX)vs ›$23.08B5.79x5.88x7.29x9.45x
BioNTech SE (BNTX)vs ›$23.07B-45.74x444.02x1201.03x1201.03x
United Therapeutics Corporation (UTHR)vs ›$23.03B77.81x54.95x40.03x35.88x
Moderna, Inc. (MRNA)vs ›$26.69B-307.40x531.75x531.75x531.75x
Incyte Corporation (INCY)vs ›$22.73B553.04x298.73x269.07x276.66x
DexCom, Inc. (DXCM)vs ›$27.07B49.83x40.70x32.97x24.93x
Labcorp Holdings Inc. (LH)vs ›$22.26B6.77x5.99x5.91x8.30x

Financial Health Indicators

Interest Coverage

1737.0x

Debt/Equity

0.13

Current Ratio

3.02

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

  • < 1.5x: EBIT is less than 1.5 times interest expense
  • 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
  • 3x - 5x: EBIT is between 3 and 5 times interest expense
  • > 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Interest Coverage Ratio FAQ

What is the interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
The interest coverage ratio for WST stock is 1737.00x.
Is West Pharmaceutical Services, Inc.'s interest coverage ratio high or low?
The interest coverage ratio of 1737.00x is 555% above its 5-year average of 265.31x, near the high end of its 5-year range (45.30x–1737.00x).
What is the TTM average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
The TTM average interest coverage ratio for WST stock is 969.93x.
What is the 3Y average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
The 3Y average interest coverage ratio for WST stock is 129.22x.
What is the 5Y average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
The 5Y average interest coverage ratio for WST stock is 89.16x.
What is the 10Y average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
The 10Y average interest coverage ratio for WST stock is 57.59x.
What is the 15Y average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
The 15Y average interest coverage ratio for WST stock is 40.05x.
What is the 20Y average interest coverage ratio for West Pharmaceutical Services, Inc. (WST)?
The 20Y average interest coverage ratio for WST stock is 33.25x.

WST Interest Coverage Ratio History

DATEINTEREST COVERAGE RATIO
2025-09-301737.00x
2025-06-301582.00x
2025-03-31321.00x
2024-09-30239.71x
2024-06-3087.20x
2024-03-3184.67x
2023-12-31155.09x
2023-09-3065.90x
2023-06-3072.04x
2023-03-3176.14x
2022-12-31101.13x
2022-09-3089.33x
2022-06-30124.39x
2022-03-3188.95x
2021-12-3158.35x
2021-09-30107.94x
2021-06-30116.61x
2021-03-31100.17x
2020-12-3145.30x
2020-09-3053.35x
2020-06-3056.95x
2020-03-3142.25x
2019-12-3141.26x
2019-09-3036.60x
2019-06-3040.84x
2019-03-3130.95x
2018-12-3139.55x
2018-09-3028.47x
2018-06-3024.82x
2018-03-3127.28x
2017-12-3128.62x
2017-09-3041.09x
2017-06-3027.00x
2017-03-3134.22x
2016-12-3160.00x
2016-09-3029.56x
2016-06-3030.60x
2016-03-3112.00x
2015-12-3115.59x
2015-09-30-0.95x
2015-06-3011.50x
2015-03-3111.66x
2014-12-3111.74x
2014-09-309.78x
2014-06-3012.88x
2014-03-319.82x
2013-12-319.46x
2013-09-309.02x
2013-06-3010.37x
2013-03-319.41x
2012-12-319.00x
2012-09-305.98x
2012-06-307.74x
2012-03-319.70x
2011-12-316.14x
2011-09-305.80x
2011-06-306.04x
2011-03-316.13x
2010-12-311.26x
2010-09-306.02x
2010-06-307.82x
2010-03-317.22x
2009-12-315.29x
2009-09-306.82x
2009-06-308.17x
2009-03-315.44x
2008-09-304.16x
2008-08-0510.14x
2008-03-319.29x
2006-03-319.40x
2005-06-306.86x
2005-03-3110.05x

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green